SANUWAVE Health, Inc. (SNWV)
NASDAQ: SNWV · Real-Time Price · USD
33.56
+0.21 (0.63%)
At close: Nov 13, 2025, 4:00 PM EST
33.56
0.00 (0.00%)
After-hours: Nov 13, 2025, 4:10 PM EST
SANUWAVE Health Market Cap
SANUWAVE Health has a market cap or net worth of $287.82 million as of November 13, 2025.
Market Cap
287.82M
Enterprise Value
306.70M
1-Year Change
n/a
Ranking
Category
Stock Price
$33.56
Market Cap Chart
Since March 7, 2025, SANUWAVE Health's market cap has increased from $247.50M to $287.82M, an increase of 16.29%. That is a compound annual growth rate of 25.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 266.50M | 17.66% |
| Nov 6, 2025 | 226.50M | -1.39% |
| Nov 5, 2025 | 229.70M | -2.50% |
| Nov 4, 2025 | 235.60M | 0.30% |
| Nov 3, 2025 | 234.90M | -5.28% |
| Oct 31, 2025 | 248.00M | 3.29% |
| Oct 30, 2025 | 240.10M | -7.94% |
| Oct 29, 2025 | 260.80M | -1.95% |
| Oct 28, 2025 | 266.00M | 0.08% |
| Oct 27, 2025 | 265.80M | 0.15% |
| Oct 24, 2025 | 265.40M | -1.26% |
| Oct 23, 2025 | 268.80M | -0.88% |
| Oct 22, 2025 | 271.20M | 4.55% |
| Oct 21, 2025 | 259.40M | -3.28% |
| Oct 20, 2025 | 268.20M | -7.74% |
| Oct 17, 2025 | 290.70M | -3.07% |
| Oct 16, 2025 | 299.90M | 5.12% |
| Oct 15, 2025 | 285.30M | 5.82% |
| Oct 14, 2025 | 269.60M | -5.64% |
| Oct 13, 2025 | 285.70M | 3.36% |
| Oct 10, 2025 | 276.40M | 0.14% |
| Oct 9, 2025 | 276.00M | 2.83% |
| Oct 8, 2025 | 268.40M | -2.15% |
| Oct 7, 2025 | 274.30M | -21.56% |
| Oct 6, 2025 | 349.70M | 9.04% |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 911.30B |
| Johnson & Johnson | 468.34B |
| AbbVie | 412.21B |
| UnitedHealth Group | 307.13B |
| AstraZeneca | 275.24B |
| Novartis AG | 251.93B |
| Merck & Co. | 226.98B |
| Abbott Laboratories | 224.00B |